You have 7 free searches left this month | for more free features.

Condition

Atypical; Mycobacterium, Pulmonary, Tuberculous (1)

HIV Infections (1)

Pulmonary Diseases (1)

Tuberculosis (1)

Overall Status

Completed (3)

Sign in for free

Phase

phase 2/phase 3 (1)

phase 3 (1)

phase 4 (1)

Sponsor

British Thoracic Society (1)

Centre Hospitalier Universitaire, Amiens (1)

Dartmouth-Hitchcock Medical Center (1)

Collaborator

National Institute of Allergy and Infectious Diseases (NIAID) (1)

Intervention

addition of ciprofloxacin to rifampicin and ethambutol (1)

addition of clarithromycin to rifampicin and ethambutol (1)

clarithromycin (1)

moxifloxacin (1)

srl-172 (1)

vaccination with m.vaccae (1)

Study Documents

Intervention Type

biological (2)

drug (2)

Funder Type

Other (3)

Study Type

Interventional (3)

M.vaccae

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Atypical; Mycobacterium, Pulmonary, Tuberculous Trial in France (Clarithromycin, Moxifloxacin)

Completed

Atypical; Mycobacterium, Pulmonary, Tuberculous

Abbeville, France
+51 more

Jul 17, 2020

Tuberculosis, HIV Trial in Dar es Salaam (SRL-172)

Completed

Tuberculosis
HIV Infections

SRL-172

Dar es Salaam, Tanzania

Muhimbili University College of Health Sciences

Feb 17, 2016

Pulmonary Diseases Trial in Penarth (Addition of clarithromycin to rifampicin and ethambutol, Addition of Ciprofloxacin to

Completed

Pulmonary Diseases

Addition of clarithromycin to rifampicin and ethambutol
+2 more

Penarth, Vale of Glamorgan, United Kingdom

Llandough Hospital

Aug 21, 2006